These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors. Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616 [TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE). Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208 [TBL] [Abstract][Full Text] [Related]
4. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Klöppel G Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112 [TBL] [Abstract][Full Text] [Related]
5. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas. Tang LH; Basturk O; Sue JJ; Klimstra DS Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015 [TBL] [Abstract][Full Text] [Related]
6. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement. Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895 [TBL] [Abstract][Full Text] [Related]
7. Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease. Miller HC; Drymousis P; Flora R; Goldin R; Spalding D; Frilling A World J Surg; 2014 Jun; 38(6):1353-61. PubMed ID: 24493070 [TBL] [Abstract][Full Text] [Related]
8. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?]. Schnabel PA; Junker K Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813 [TBL] [Abstract][Full Text] [Related]
9. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms? Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria. Farrell JM; Pang JC; Kim GE; Tabatabai ZL Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931 [TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737 [TBL] [Abstract][Full Text] [Related]
12. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts. Kim JY; Hong SM Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301 [TBL] [Abstract][Full Text] [Related]
13. [Accurate grading of pancreatic neuroendocrine tumors with Ki-67 index in fine-needle aspiration specimens: a comparative cytologic and histologic study]. He SR; Cui D; Gong H; Zhu YP; Chen L; Hu ST; Liu DG Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):393-399. PubMed ID: 28591986 [No Abstract] [Full Text] [Related]
14. [Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future]. Scoazec JY; Couvelard A; Ann Pathol; 2017 Dec; 37(6):444-456. PubMed ID: 29169836 [TBL] [Abstract][Full Text] [Related]
15. Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors. Karakuş E; Helvacı A; Ekinci O; Dursun A Turk J Gastroenterol; 2014 Feb; 25(1):81-7. PubMed ID: 24918137 [TBL] [Abstract][Full Text] [Related]
17. [Pathology of important diseases of endocrine organs (excluding the thyroid)]. Saeger W; Schröder S; Klöppel G Pathologe; 2001 Sep; 22(5):296-309. PubMed ID: 11572110 [TBL] [Abstract][Full Text] [Related]
18. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112 [TBL] [Abstract][Full Text] [Related]
19. Grading of neuroendocrine neoplasms: mitoses and Ki-67 are both essential. van Velthuysen ML; Groen EJ; van der Noort V; van de Pol A; Tesselaar ME; Korse CM Neuroendocrinology; 2014; 100(2-3):221-7. PubMed ID: 25358267 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors. Özaslan E; Demir S; Karaca H; Güven K Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]